Prevalence of Pathogenic Germline Variants in Women with Non-Familial Unilateral Triple-Negative Breast Cancer

INTRODUCTION: International guidelines recommend genetic testing for women with familial breast cancer at an expected prevalence of pathogenic germline variants (PVs) of at least 10%. In a study sample of the German Consortium for Hereditary Breast and Ovarian Cancer (GC-HBOC), we have previously sh...

Descripción completa

Detalles Bibliográficos
Autores principales: Rhiem, Kerstin, Zachariae, Silke, Waha, Anke, Grill, Sabine, Hester, Anna, Golatta, Michael, van Mackelenbergh, Marion, Fehm, Tanja, Schlaiß, Tanja, Ripperger, Tim, Ledig, Susanne, Meisel, Cornelia, Speiser, Dorothee, Veselinovic, Kristina, Schröder, Christopher, Witzel, Isabell, Gallwas, Julia, Weber, Bernhard H.F., Solbach, Christine, Aktas, Bariyhe, Hahnen, Eric, Engel, Christoph, Schmutzler, Rita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10228253/
https://www.ncbi.nlm.nih.gov/pubmed/37261134
http://dx.doi.org/10.1159/000528972

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10228253/
https://www.ncbi.nlm.nih.gov/pubmed/37261134
http://dx.doi.org/10.1159/000528972

Ejemplares similares